Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LiFeng Tian

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Nature|February 4, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomesXueqing Zoe Zou, Fengyuan Hu, Haiyi Lou, et al.
American Journal of Human Genetics|June 5, 2013
Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosisJohn A Martignetti, Lifeng Tian, Dong Li, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
BMJ (Clinical Research Ed.)|February 17, 2026
Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trialKai-Lun Hu, Tingting Liao, Qiongfang Wu, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Scientific Reports|March 8, 2016
An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity DisorderLeandro de Araújo Lima, Ana Cecília Feio-dos-Santos, Sintia Iole Belangero, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Nature|February 4, 2026
Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomesXueqing Zoe Zou, Fengyuan Hu, Haiyi Lou, et al.
American Journal of Human Genetics|June 5, 2013
Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosisJohn A Martignetti, Lifeng Tian, Dong Li, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
BMJ (Clinical Research Ed.)|February 17, 2026
Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trialKai-Lun Hu, Tingting Liao, Qiongfang Wu, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Scientific Reports|March 8, 2016
An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity DisorderLeandro de Araújo Lima, Ana Cecília Feio-dos-Santos, Sintia Iole Belangero, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Pageof 15